Screener
Immix Biopharma, Inc. IMMX Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Immix Biopharma, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
FAQ
- What is Immix Biopharma, Inc.'s debt-to-equity?
- Immix Biopharma, Inc. (IMMX) reported debt-to-equity of 0× in Q1 2026.
- How has Immix Biopharma, Inc.'s debt-to-equity changed year-over-year?
- Immix Biopharma, Inc.'s debt-to-equity decreased by 88.9% year-over-year, from 0.1× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Immix Biopharma, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude